Avanos Medical Inc’s recent filing unveils that its SVP – Chief Financial Officer Greiner Michael unloaded Company’s shares for reported $0.15 million on Mar 14 ’24. In the deal valued at $19.12 per share,8,000 shares were sold. As a result of this transaction, Greiner Michael now holds 151,495 shares worth roughly $2.96 million.
Then, Shimer Julie Ann bought 500 shares, generating $9,925 in total proceeds. Upon buying the shares at $19.85, the Director now owns 50,090 shares.
KeyBanc Capital Markets downgraded its Avanos Medical Inc [AVNS] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Stephens also remained covering AVNS and has decreased its forecast on August 04, 2021 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Barclays revised its rating on April 13, 2020. It rated AVNS as “an Equal weight” which previously was an “an Underweight”.
Price Performance Review of AVNS
On Tuesday, Avanos Medical Inc [NYSE:AVNS] saw its stock fall -0.96% to $19.54. Over the last five days, the stock has gained 8.08%. Avanos Medical Inc shares have fallen nearly -12.88% since the year began. Nevertheless, the stocks have fallen -18.48% over the past one year. While a 52-week high of $26.56 was reached on 01/02/24, a 52-week low of $17.24 was recorded on 01/05/24. SMA at 50 days reached $19.19, while 200 days put it at $20.34. A total of 0.21 million shares were traded, compared to the trading of 0.25 million shares in the previous session.
Levels Of Support And Resistance For AVNS Stock
The 24-hour chart illustrates a support level at 19.42, which if violated will result in even more drops to 19.31. On the upside, there is a resistance level at 19.76. A further resistance level may holdings at 19.99. The Relative Strength Index (RSI) on the 14-day chart is 55.85, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 21.87%. Stochastics %K at 84.08% indicates the stock is a selling.
